Improving outcomes in breast cancer for low and middle income countries

World Journal of Surgery
C H YipP S Y Cheung


Breast cancer is the most common cancer in women world-wide. Incidence rates in low- and middle-income countries (LMICs) are lower than in high income countries; however, the rates are increasing very rapidly in LMICs due to social changes that increase the risk of breast cancer. Breast cancer mortality rates in LMICs remain high due to late presentation and inadequate access to optimal care. Breast Surgery International brought together a group of breast surgeons from different parts of the world to address strategies for improving outcomes in breast cancer for LMICs at a symposium during International Surgical Week in Helsinki, Finland in August 2013. A key strategy for early detection is public health education and breast awareness. Sociocultural barriers to early detection and treatment need to be addressed. Optimal management of breast cancer requires a multidisciplinary team. Surgical treatment is often the only modality of treatment available in low-resource settings where modified radical mastectomy is the most common operation performed. Chemotherapy and radiotherapy require more resources. Endocrine therapy is available but requires accurate assessment of estrogen receptors status. Targeted therapy with trastuzumab is...Continue Reading


Sep 1, 1994·Annals of Surgery·A E GiulianoD L Morton
Mar 10, 2001·Journal of the National Cancer Institute·B RockhillG A Colditz
Oct 3, 2002·Journal of the National Cancer Institute·David B ThomasSteven G Self
Apr 26, 2003·The Breast Journal·Robert W CarlsonUNKNOWN Global Summit Treatment Panel
Jul 29, 2005·International Journal of Cancer. Journal International Du Cancer·Paola PisaniAdriano Laudico
Dec 31, 2005·Clinical Breast Cancer·Gabriel N HortobagyiUNKNOWN ABREAST Investigators
Jan 25, 2006·The Breast Journal·Roman ShyyanUNKNOWN Global Summit Diagnosis and Pathology Panel
Jan 25, 2006·The Breast Journal·Alexandru EniuUNKNOWN Global Summit Treatment and Allocation of Resources Panel
Jan 18, 2008·The New England Journal of Medicine·Peggy Porter
Jul 22, 2008·The Lancet Oncology·Michel P ColemanUNKNOWN CONCORD Working Group
Oct 7, 2008·Cancer·Cheng-Har YipUNKNOWN Breast Health Global Initiative Early Detection Panel
Oct 7, 2008·Cancer·Roman ShyyanUNKNOWN Breast Health Global Initiative Diagnosis Panel
Oct 7, 2008·Cancer·Alexandru EniuUNKNOWN Breast Health Global Initiative Treatment Panel
Oct 7, 2008·Cancer·Joe HarfordUNKNOWN Breast Health Global Initiative Healthcare Systems Panel
Oct 7, 2008·Cancer·Richard R Love
Jul 8, 2010·World Journal of Surgery·Stanley P L LeongWilliam D Foulkes
Feb 25, 2011·The Breast : Official Journal of the European Society of Mastology·Gustavo AzenhaCristina Parsons Perez
Feb 26, 2011·The Breast : Official Journal of the European Society of Mastology·C H YipA Rhodes
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Mar 12, 2011·The Breast : Official Journal of the European Society of Mastology·Nagi S El SaghirEduardo Cazap
Mar 13, 2012·International Journal of Cancer. Journal International Du Cancer·C R Beena DeviMarilys Corbex
Oct 9, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Nirmala Bhoo-PathyHelena M Verkooijen
May 15, 2013·Lancet·Peter C Gøtzsche, Karsten Juhl Jørgensen
May 15, 2013·Lancet·Alberto Donzelli
Jun 8, 2013·British Journal of Cancer·M G MarmotM Wilcox
Jul 28, 2013·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·Asmerom TesfamariamJacob Mufunda
Mar 22, 2014·BMC Cancer·Gerard C C LimUNKNOWN HPMRS Breast Cancer Study Group

❮ Previous
Next ❯


Dec 30, 2017·The Breast Journal·Vasco Fonseca, Margarida Brito
Aug 28, 2019·Journal of Global Oncology·Rupali SoodSusan C Harvey
Nov 3, 2017·Journal of Global Oncology·Lindsay K DickersonSusan C Harvey
Dec 5, 2020·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Waliu Jawula SalisuKhatereh Seylani

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved